DDAH1 and hypertensive disorder: Consistent with these observations, mice with a genetic disruption of endothelial NOS display hyperlipidemia, hypertension, and IR, whereas mice overexpressing human dimethylarginine dimethylaminohydrolase 1 (DDAH1), the enzyme mainly responsible for degrading ADMA, show increased insulin sensitivity [14, 15].